Stiles Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,126
Closed -$586K 185
2024
Q3
$586K Sell
1,126
-15
-1% -$8.01K 0.21% 99
2024
Q2
$618K Sell
1,141
-18
-2% -$9.51K 0.24% 92
2024
Q1
$602K Sell
1,159
-21
-2% -$10.4K 0.24% 97
2023
Q4
$557K Buy
1,180
+1
+0.1% +$462 0.25% 97
2023
Q3
$514K Sell
1,179
-8
-0.7% -$3.63K 0.27% 99
2023
Q2
$527K Sell
1,187
-12
-1% -$5.54K 0.26% 99
2023
Q1
$551K Buy
1,199
+4
+0.3% +$1.9K 0.3% 93
2022
Q4
$613K Sell
1,195
-17
-1% -$8.63K 0.35% 83
2022
Q3
$551K Sell
1,212
-7
-0.6% -$3.35K 0.33% 81
2022
Q2
$588K Sell
1,219
-12
-1% -$5.94K 0.35% 79
2022
Q1
$605K Sell
1,231
-62
-5% -$28.3K 0.3% 92
2021
Q4
$599K Buy
+1,293
New +$544K 0.29% 96

Other funds holding ELV

Stiles Financial Services's ELV Position: Q4 2024 in Review

Stiles Financial Services sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,126 shares — an estimated $586K sold.

Stiles Financial Services first reported a position in ELV in Q4 2021 and held it in 12 quarters. The position peaked at $618K in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Stiles Financial Services reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Stiles Financial Services sold 1,126 Elevance Health shares in Q4 2024, an estimated $586K.
  • Stiles Financial Services first reported a position in Elevance Health in Q4 2021 and held it in 12 quarters.
  • Stiles Financial Services's Elevance Health position peaked at $618K in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Stiles Financial Services's 13F filing for Q4 2024, filed 28 Jan 2025.